SVB Leerink started coverage on shares of Neurogene (NASDAQ:NGNE – Free Report) in a research note published on Monday, Marketbeat reports. The firm issued an outperform rating and a $46.00 price target on the stock. NGNE has been the subject of a number of other research reports. William Blair began coverage on Neurogene in a […]
SVB Leerink initiated coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a report released on Monday morning, Marketbeat Ratings reports. The firm issued an outperform rating and a $74.00 target price on the stock. Several other analysts have also recently commented on IMCR. Needham & Company LLC reiterated a buy rating and issued […]
Stock analysts at SVB Leerink initiated coverage on shares of XOMA (NASDAQ:XOMA – Get Free Report) in a research report issued on Monday, Briefing.com reports. The firm set an “outperform” rating and a $40.00 price target on the biotechnology company’s stock. SVB Leerink’s price target points to a potential upside of 57.42% from the company’s […]
Nuvalent (NASDAQ:NUVL – Get Free Report) was upgraded by research analysts at SVB Leerink from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm currently has a $110.00 target price on the stock, up from their previous target price of […]
Stock analysts at SVB Leerink initiated coverage on shares of Sagimet Biosciences (NASDAQ:SGMT – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The firm set an “outperform” rating and a $26.00 price target on the stock. SVB Leerink’s price target suggests a potential upside of 476.50% […]